Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity? [electronic resource]
Producer: 20031211Description: 107-13 p. digitalISSN:- 0021-9150
- Adult
- Antiretroviral Therapy, Highly Active
- Apolipoprotein A-I -- metabolism
- Apolipoprotein C-III
- Apolipoproteins B -- metabolism
- Apolipoproteins C -- metabolism
- Biomarkers -- blood
- Cholesterol, HDL -- metabolism
- Female
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- immunology
- Humans
- Lipoproteins, LDL -- drug effects
- Lipoproteins, VLDL -- metabolism
- Lopinavir
- Male
- Phospholipids -- metabolism
- Pyrimidinones -- immunology
- Ritonavir -- immunology
- Statistics as Topic
- Time Factors
- Treatment Outcome
- Triglycerides -- metabolism
- Viral Load
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.